Mergers & Acquisitions
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma M&A deals, divestitures, and partnerships. Gain critical intelligence for strategic investment and business development in life sciences.
Showing 37–48 of 73 articles
Servier $2.65B Muscular Dystrophy Asset Deal
BMS-Hengrui $15B Deal: Strategic Implications for Pharma Executives
Eli Lilly Acquires Engage Bio to Advance Non-Viral Genetic Medicines
Longeveron 2026 Strategy: Asset-Light Partnering Pivot
TrumpRx Expands Generic Drug Offerings: Implications for Pharma BD and Investors
Eli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease
White House Taps Amazon, GoodRx to Expand TrumpRx Generic Drug Access
Big Pharma's Shift to Smaller Deals Boosts Biotech Sector
Rallybio Taps Avenzo Therapeutics for Reverse Merger to Advance Oncology Pipeline
Rallybio Pursues Reverse Merger with Avenzo Therapeutics to Advance Autoimmune Pipeline
Merck's ADC Success: Insights from Global Trial Results
Niowave's $75M Radiopharmaceutical Plant: Industry Implications